SCA Pharmaceuticals is recalling 3,932 bags of Heparin Sodium 5,000 units in 0.9% Sodium Chloride (5 units/mL) due to test results showing the drug is subpotent. This prescription medication, used to prevent blood clots, was found to have out-of-specification potency levels during a 30-day stability check. The affected 1000 mL bags were distributed nationwide to healthcare facilities. Consumers should contact their healthcare provider or pharmacist immediately, as a subpotent drug may not provide the intended therapeutic effect.
If the Heparin Sodium solution is subpotent, it may fail to effectively prevent or treat blood clots, potentially leading to serious thromboembolic events such as deep vein thrombosis or pulmonary embolism.
Refund for subpotent drug product
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.